Medical technology industry is of the view that the Union government should on top priority enforce a dedicated medical device regulation. It should now take immediate steps to amend the Drugs & Cosmetics Act Schedule M 111 Rule 76 move away from the current regulation separating medical devices from drugs considering patient safety and efficacy.